Posted inNews and Updates
FDA Clears Clinical Trial for Novel Peanut Allergy Drug LP-3
Longbio Pharma has received FDA clearance to begin clinical trials for LP-3, a potential new treatment targeting life-threatening peanut allergies.
Posted inNews and Updates
QAIAx Clinical Trial: Novel AGI-Driven Mental Health Care
The QAIAx clinical trial explores how AGI can support veteran mental health through alternative sentencing and VR-based pro-social dating programs.
Posted inNews and Updates
Leqembi Subcutaneous Injection: New Alzheimer’s Data Revealed
New trial data shows the Leqembi subcutaneous autoinjector offers similar efficacy to IV infusions, promising a more accessible future for Alzheimer’s care.
Posted inNews and Updates
Is BridgeBio Pharma Undervalued After Recent Clinical News?
Despite recent clinical setbacks for Wainua, analysts weigh in on BridgeBio Pharma’s potential. Is the biotech stock undervalued? Read the latest analysis.
Posted inNews and Updates
Record-Breaking Ebola Clinical Trial Begins in DR Congo
A groundbreaking clinical trial has begun in the DRC to test advanced Ebola treatments. Discover how this study aims to lower mortality rates worldwide.
Posted inNews and Updates
Denecimig Shows Consistent Efficacy in Hemophilia A Patients
New trial data shows denecimig offers consistent safety and efficacy for hemophilia A patients across all age groups. Learn the latest clinical findings.
Posted inNews and Updates
Maharashtra FDA Recalls Cadila Pharma’s Aciloc Over Branding
The Maharashtra FDA has ordered a recall of Cadila Pharma’s Aciloc worth Rs 2.45 crore due to deceptive branding. Learn the details behind the major move.
Posted inNews and Updates
Marksans Pharma Expands EU Reach With ABCnow Acquisition
Marksans Pharma to acquire German-based ABCnow GmbH, aiming to expand its EU market presence and streamline drug distribution and regulatory operations.
Posted inNews and Updates
Beyond GLP-1: Could GLP-3 Drugs Revolutionize Weight Loss?
A new class of GLP-3 drugs is showing significant promise in Phase 3 trials for weight loss and diabetes. Learn how this breakthrough may reshape metabolic care.
Posted inNews and Updates
New GLP-1 Implant Could Revolutionize Long-Term Weight Loss
A new miniature GLP-1 implant aims to simplify weight loss maintenance, offering a consistent alternative to injections. Discover the future of obesity care.